Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers
Clinical trial NCT02253823 · COMPLETED
Trial details
- NCT number
- NCT02253823
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Primary completion
- 2002-03-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.